Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151978 | SCV000200528 | uncertain significance | not specified | 2013-04-06 | criteria provided, single submitter | clinical testing | The Asp1136His variant in TECTA has been reported in a Spanish family with domin ant postlingual mid-frequency hearing loss (Hildebrand 2011); however, the autho rs did not report the number of family members who were tested and whether the v ariant co-segregated in all affected members. This variant has also been identif ied in 0.05% (2/4406) of African American chromosomes by the NHLBI Exome Sequenc ing Project and in 1/100 (1%) Puerto Rican chromosomes by the 1000 Genomes Proje ct (http://evs.gs.washington.edu/EVS/; dbSNP rs147890616). Although, this varian t has been reported in the general population, its frequency is not high enough to rule out a pathogenic role. Computational analyses (biochemical amino acid pr operties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong su pport for or against an impact to the protein. In summary, additional informatio n is needed to fully assess the clinical significance of this variant. |
Eurofins Ntd Llc |
RCV000726310 | SCV000343651 | uncertain significance | not provided | 2016-08-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763711 | SCV000894591 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 12; Autosomal recessive nonsyndromic hearing loss 21 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001103636 | SCV001260427 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 21 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001103637 | SCV001260428 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 12 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV000726310 | SCV001789164 | uncertain significance | not provided | 2024-06-11 | criteria provided, single submitter | clinical testing | Reported in association with autosomal dominant hearing loss in published literature (PMID: 21520338); In silico analysis indicates that this missense variant does not alter protein structure/function; Located in the von Willebrand factor type D3 subdomain of the zonadhesin domain (PMID: 21520338, 31554319, 9590290); This variant is associated with the following publications: (PMID: 25262649, 30245029, 27368438, 21520338, 31554319, 9590290) |
Labcorp Genetics |
RCV000726310 | SCV002165013 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000726310 | SCV001960141 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000726310 | SCV001974790 | uncertain significance | not provided | no assertion criteria provided | clinical testing |